(Q44555689)

4 December 2017

Silibinin protects mice from T cell-dependent liver injury (English)

1 reference

4 December 2017

3

1 reference

4 December 2017

6

Gisa Tiegs

0 references

Angelika Vollmar

4

object named as

Angelika M Vollmar

1 reference

4 December 2017

Jens Schümann

1

1 reference

4 December 2017

Jennifer Prockl

2

1 reference

4 December 2017

Renate Bang

5

1 reference

4 December 2017

Gisa Tiegs

6

1 reference

4 December 2017

1 September 2003

1 reference

4 December 2017

Journal of Hepatology

1 reference

4 December 2017

39

1 reference

4 December 2017

3

1 reference

4 December 2017

333-340

1 reference

Hepatitis B virus immunopathogenesis

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Cytokines in viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Pathogenesis of autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Pathophysiological mechanisms of TNF during intoxication with natural or man-made toxins

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

A T cell-dependent experimental liver injury in mice inducible by concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Importance of Kupffer cells for T-cell-dependent liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Critical contribution of liver natural killer T cells to a murine model of hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

In vivo regulation of inducible no synthase in immune-mediated liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Inducible nitric oxide synthase is critical for immune-mediated liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Herbal products for liver diseases: a therapeutic challenge for the new millennium

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

The use of silymarin in the treatment of liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Mechanism for the protective effects of silymarin against carbon tetrachloride-induced lipid peroxidation and hepatotoxicity in mice. Evidence that silymarin acts both as an inhibitor of metabolic activation and as a chain-breaking antioxidant

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Prevention by silymarin of membrane alterations in acute CCl4 liver damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Silymarin protects against paracetamol-induced lipid peroxidation and liver damage

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Protective Activity of Silipide on Liver Damage in Rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Effect of silymarin on different acute inflammation models and on leukocyte migration

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Concanavalin A hepatotoxicity in mice: tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Cytokine expression in three mouse models of experimental hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Low-molecular-weight hyaluronic acid induces nuclear factor-kappaB-dependent resistance against tumor necrosis factor alpha-mediated liver injury in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Leukocyte alterations do not account for hepatitis induced by endotoxin or TNF alpha in galactosamine-sensitized mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Mechanisms of interleukin-10-mediated immune suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Production and role of interleukin-10 in concanavalin A-induced hepatitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Concanavalin A-induced hepatitis in mice is prevented by interleukin (IL)-10 and exacerbated by endogenous IL-10 deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900239-3

7 January 2021

10.1016/S0168-8278(03)00239-3

Identifiers

DOI

1 reference

4 December 2017

1 reference